Nicaragua vs Oman: HIV-positive TB patients on ART (antiretroviral therapy)
Nicaragua
100.0%
in 2023
Oman
100.0%
in 2024
Nicaragua rank
1st
Oman rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Nicaragua
- Oman
How they compare
Nicaragua currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 5 times across 14 shared years of data; in 2008 it was Oman ahead.
Nicaragua ranks 1st and Oman ranks 1st of 144 countries.
Across the 3 decades both report, Nicaragua averaged higher in 1 and Oman in 2.
Head to head by decade
| Decade | Nicaragua | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.0% | 100.0% | 3.0% | Oman |
| 2010s | 87.4% | 91.4% | 4.0% | Oman |
| 2020s | 98.2% | 89.2% | 9.0% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Nicaragua or Oman?
- Nicaragua, at 100.0% against 100.0% in Oman as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Nicaragua and Oman?
- 0.0%, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Oman?
- 14 years are reported by both, from 2008 to 2023.
- How do Nicaragua and Oman rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Nicaragua ranks 1st and Oman ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.